Evidence map›Paper›PMID 31376406›Full record

ArticleThe Journal of allergy and clinical immunology2019

Cell-based biosensors for immunology, inflammation, and allergy.

Maria Eugenia Inda, Mark Mimee, Timothy K Lu

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of allergy and clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Living Microbial Drugs.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maria Eugenia IndaMIT Synthetic Biology Center, Massachusetts Institute of Technology, Cambridge, Mass; Research Laboratory of Electronics, Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Mass.
Mark MimeeMIT Synthetic Biology Center, Massachusetts Institute of Technology, Cambridge, Mass; Research Laboratory of Electronics, Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Mass. Electronic address: mmimee@mit.edu.
Timothy K LuMIT Synthetic Biology Center, Massachusetts Institute of Technology, Cambridge, Mass; Research Laboratory of Electronics, Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Mass; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Mass. Electronic address: timlu@mit.edu.

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Engineering “Phagebody” Antimicrobials for Carbapenem-Resistant EnterobacteriaceaeR33AI121669 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LU, TIMOTHY · 2018 to 2020
$1.3M
NIAID NIH HHS R33 AI121669NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biosensing TechniquesAnimalsBacteriaHumansHypersensitivityImmune System PhenomenaInflammationbiomedical applicationsbiosensorbiotechnologydiagnosisgene circuitSynthetic biologytreatment

Identifiers

PMID31376406
PMCPMC12063492

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.